/>

Monday, April 8, 2019

NEWS 08 APR 2019

NEWS FROM USA

Paragraph IV filing

DRUG

Dosage form

Corresponding RLD

Date of Submission

Type of Submission (Based on Date)

Canagliflozin And Metformin Hydrochloride

ER Tablets

Invokamet XR

21 Nov 2018

Post NCE-1

 

NEW GENERICS LAUNCHES IN US

 DRUG

COMPANY

Corresponding RLD

Annual sales quoted in press release as per IQVIA 

Press Release

Capecitabine Tablets

Armas pharma

Xeloda

$108 Million

Link

Imatinib Tablets

Armas Pharma

Gleevec

$655 Million

Link

Albuterol sulphate  Aerosol

Endo

Proventil

N/A

Link

 

NDA Approvals

Approval Date

Drug

NDA Sponsor

Brand Name

Prescribing information

03 Apr 2019

Colesevelam Hydrochloride Oral Bar

Daiichi Sankyo

Welchol

Link

 

ANDA Approvals

Approval Date

Drug Product

ANDA

Sponsor

Corresponding RLD

Number Of Other Approved Generics

02 Apr 2019

Selegiline Hydrochloride Capsules

Pack Pharms

Eldepryl

(Somerset)

Two

02 Apr 2019

Bupivacaine hydrochloride Injectable

B Braun

Marcaine (Hospira)

Two

02 Apr 2019

Carmustine Injection

Sti Pharma

Bicnu

(Emcure)

Two

03 Apr 2019

Estradiol; Norethindrone Acetate Tablets

Novast Labs

Activella (Amneal)

Four

03 Apr 2019

Permethrin Cream

Encube Ethicals

Elimite

(Mylan)

Two

03 Apr 2019

Fluocinonide Cream

Teligent Pharma

Vanos

(Medicis)

Five

04 Apr 2019

Losartan Potassium Tablets

Hisun Pharm

Cozaar

(Merck)

More Than 10

04 Apr 2019

Pitavastatin Calcium Tablets

Mylan

Livalo

(Kowa)

Three

04 Apr 2019

Olopatadine Hydrochloride Solution

Aurobindo

Pataday (Novartis)

Four

 

Tentative ANDA Approvals

Approval Date

Drug

Company

02 Apr 2019

Fingolimod

Hec Pharm

05 Apr 2019

Lacosamide

Zydus Pharms

05 Apr 2019

Tofacitinib Citrate

Zydus Pharms

08 Apr 2019

Bortezomib

Shilpa Medicare

 

Other News from the USA

Sun Pharma Launches Ready-to-Infuse INFUGEM in the U.S

If you have any query/suggestion then please write us at pharmacaption@gmail.com

No comments:

Post a Comment